Immunocore Touts Updated Phase 1 Results for Melanoma Asset Brenetafusp

Seeking Alpha04:31

Express News | NYSE Order Imbalance 1870132.0 Shares on Sell Side

Breakings03:50

FDA Expands Approval For Bristol Myers Squibb's Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies

On Thursday, the FDA approved Bristol Myers Squibb Co's (NYSE:BMY) Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for relapsed or refrac

Benzinga02:14

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

Benzinga01:35

Novartis Boasts Scemblix Beats Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

Seeking Alpha00:19

Express News | Bristol-Myers Squibb's CAR-T therapy was approved by the US FDA

BreakingsMay 31 09:07